Type 1 Diabetes

Significantly better than standard of care at 12 and 24 weeks

Beta-hydroxybutyrate-based stopping point reduced burden on patients

Diabetic nephropathy was most common of the fatal complications, study showed

780G system first to feature meal detection technology

Kids ages 2 to 5 saw significant benefits with hybrid closed-loop system

Casting a light on profiteering methods of price mediators

But intensive glucose control didn't preserve pancreatic C-peptide secretion

A 33-year-old woman went to the doctor after noticing painful lumps on her legs that had developed over the past few days, some of which had begun to drain pus. Can you diagnose the patient?

Report uses 2020 claims data to estimate potential effects of IRA's $35 monthly insulin cap

Users spent twice as much time in target glucose range vs standard insulin therapy, study showed

We must explore how new technologies can help

Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all

Health news and commentary from around the Web gathered by MedPage Today staff

More than a million Americans may be engaging in the risky practice, researchers said